SCHEMBL10107139

SCHEMBL10107139

CCC(CNCc1ccccc1)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.58
RAB9A P51151 5/20 0.36
NPC1 O15118 4/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPK8 P45983 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.33
TSHR P16473 2/20 0.33
USP2 O75604 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565354 1.00 PROKR2 (0.58) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL565524 0.91 PROKR2 (0.69) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL565109 0.91 PROKR2 (0.69) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL15693909 0.91 PROKR2 (0.69) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL10107144 0.88 PROKR2 (0.59) PROKR2ALDH1A1TSHRHTTHPGD
SCHEMBL565505 0.88 PROKR2 (0.59) PROKR2ALDH1A1TSHRHTTHPGD
SCHEMBL565087 0.88 PROKR2 (0.65) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL565858 0.85 PROKR2 (0.56) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL10119874 0.85 PROKR2 (0.56) PROKR2RAB9ANPC1ALDH1A1MAPK8
SCHEMBL565475 0.85 PROKR2 (0.56) PROKR2RAB9ANPC1ALDH1A1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885RAB9A 1704/4885NPC1 3472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.